TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Reassessing main Eastern battlefield's role vital to safeguarding peace today
- China, Myanmar, Thailand hold ministerial-level meeting on telecom and cyberspace
- Prado in virtual reality
- Shantou education department suspends classes due to Typhoon Danas
- China's scientists make breakthrough on how H5N1 influenza occurred in US
- Civil Aviation Administration of China announces a new extension of M503 flight route
